Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus (Q35175233)

6 August 2017

1 reference

title

Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus (English)

1 reference

6 August 2017

Keller MJ

1

1 reference

6 August 2017

Klotman ME

series ordinal

2

1 reference

6 August 2017

Herold BC

series ordinal

3

1 reference

6 August 2017

language of work or name

1 reference

1 May 2003

1 reference

American Journal of Reproductive Immunology

6 August 2017

1 reference

6 August 2017

49

1 reference

6 August 2017

5

1 reference

6 August 2017

279-284

1 reference

Recommendations for the clinical development of topical microbicides: an update

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Phase 1 trial of nonoxynol-9 film among sex workers in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Efficacy of 9-(2-phosphonylmethoxyethyl)adenine treatment against chronic simian immunodeficiency virus infection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Gender differences in HIV-1 diversity at time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Herpes simplex virus infection induces replication of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

New targets for inhibitors of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Bile salts: natural detergents for the prevention of sexually transmitted diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

From the Centers of Disease Control and Prevention. CDC statement on study results of product containing nonoxynol-9

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

The transmission of AIDS: the case of the infected cell

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

The transmission of HIV and factors influencing progression to AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Human immunodeficiency virus type 1 RNA shedding in the female genital tract

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

Molecular basis of latency in pathogenic human viruses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2003.00044.X

7 January 2021

10.1034/J.1600-0897.2003.00044.X

Identifiers

DOI

1 reference

6 August 2017

1 reference